SCHEMBL7770223

SCHEMBL7770223

CC(CO)OC(=O)CC(O)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
OR51E2 Q9H255 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP3 P08254 1/20 0.41
MMP9 P14780 1/20 0.41
MMP13 P45452 1/20 0.41
TET2 Q6N021 5/20 0.38
TET3 O43151 1/20 0.38
TET1 Q8NFU7 1/20 0.38
PRKCA P17252 1/20 0.36
TP53 P04637 1/20 0.33
GPR84 Q9NQS5 3/20 0.31
PGK1 P00558 1/20 0.31
PGK2 P07205 1/20 0.31
FFAR1 O14842 1/20 0.31
KDM4A O75164 1/20 0.31
KDM4C Q9H3R0 1/20 0.31
KDM2A Q9Y2K7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26950788 0.81 TDP1 (0.39) MMP1MMP2MMP3MMP9MMP13
SCHEMBL31690837 0.81 TDP1 (0.39) MMP1MMP2MMP3MMP9MMP13
SCHEMBL24414474 0.81 TDP1 (0.39) MMP1MMP2MMP3MMP9MMP13
SCHEMBL305578 0.81 SMN1; SMN2 (0.48) OR51E2SMN1; SMN2MMP1MMP2MMP3
SCHEMBL5179489 0.79 OR51E2 (0.48) OR51E2SMN1; SMN2MMP1MMP2MMP3
SCHEMBL26073653 0.78 SMN1; SMN2 (0.38) SMN1; SMN2MMP1MMP2MMP3MMP9
SCHEMBL10879307 0.78 OR51E2 (0.46) OR51E2SMN1; SMN2MMP1MMP2MMP3
SCHEMBL18219230 0.78 SMN1; SMN2 (0.44) OR51E2SMN1; SMN2MMP1MMP2MMP3
SCHEMBL16928435 0.78 SMN1; SMN2 (0.44) OR51E2SMN1; SMN2MMP1MMP2MMP3
SCHEMBL18219117 0.74 MMP1 (0.44) OR51E2SMN1; SMN2MMP1MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831774-B1 ORAL DOSAGE AND METHOD FOR TREATING PAINFUL CONDITIONS OF THE ORAL CAVITY ALZA CORP (US) 2001-07-11 EP disclosed
US-5897878-A ORALLY ADMINISTERING DELIVERY SYSTEM IN WHICH FLUID IMBIBITION CAUSES HYDROPHILIC POLYMER TO AGGREGATE IN SITU IN PRESENCE OF POLYHYDROXY COMPOUND AND CAUSES PUSH LAYER TO ABSORB FLUID AND DELIVER AGGREGATES CONTAINING STEROID ALZA CORPORATION (US) 1999-04-27 US disclosed
US-5830501-A DRUG DELIVERY TO MUCOSAL TISSUE, SEMIPERMEABLE WALL, PRECIPITATION ALZA CORPORATION (US) 1998-11-03 US disclosed
EP-0831774-A1 ORAL DOSAGE AND METHOD FOR TREATING PAINFUL CONDITIONS OF THE ORAL CAVITY ALZA CORPORATION (US) 1998-04-01 EP disclosed
US-5713852-A Oral dosage and method for treating painful conditions of the oral cavity ALZA CORPORATION (US) 1998-02-03 US disclosed
WO-1996040050-A1 ORAL DOSAGE AND METHOD FOR TREATING PAINFUL CONDITIONS OF THE ORAL CAVITY ALZA CORPORATION (US) 1996-12-19 WO disclosed
US-5266332-A Oral administering of drugs with semipermeable walls and multicompartment polymer with electrolyte ALZA CORPORATION (US) 1993-11-30 US disclosed
US-5254349-A Flocculating drug and hydrophilic polymer in dosage form ALZA CORPORATION (US) 1993-10-19 US disclosed
US-5200195-A Reducing stickiness of a dosage for to biological tissue in fluid environment of use ALZA CORPORATION (US) 1993-04-06 US disclosed